Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,251
Closed -$209K 295
2022
Q4
$209K Buy
+1,251
New +$195K 0.01% 256
2022
Q2
Sell
-1,257
Closed -$301K 292
2022
Q1
$301K Hold
1,257
0.02% 225
2021
Q4
$344K Buy
1,257
+6
+0.5% +$1.67K 0.02% 219
2021
Q3
$313K Hold
1,251
0.02% 193
2021
Q2
$299K Sell
1,251
-19
-1% -$4.57K 0.02% 199
2021
Q1
$316K Buy
1,270
+219
+21% +$54.1K 0.02% 175
2020
Q4
$252K Hold
1,051
0.02% 185
2020
Q3
$226K Buy
+1,051
New +$208K 0.02% 204
2019
Q3
Sell
-1,051
Closed -$216K 233
2019
Q2
$216K Hold
1,051
0.02% 211
2019
Q1
$203K Sell
1,051
-1,050
-50% -$191K 0.02% 221
2018
Q4
$335K Hold
2,101
0.03% 175
2018
Q3
$307K Sell
2,101
-217
-9% -$30.1K 0.03% 191
2018
Q2
$281K Hold
2,318
0.02% 207
2018
Q1
$295K Buy
+2,318
New +$284K 0.03% 194
2017
Q4
Sell
-2,446
Closed -$258K 187
2017
Q3
$258K Buy
2,446
+345
+16% +$35.6K 0.02% 178
2017
Q2
$204K Buy
+2,101
New +$196K 0.02% 200

Other funds holding WDAY

Aspiriant LLC's WDAY Position: Q1 2023 in Review

Aspiriant LLC sold out of Workday (WDAY) in Q1 2023, closing a stake of 1,251 shares — an estimated $209K sold.

Aspiriant LLC first reported a position in WDAY in Q2 2017 and held it in 16 quarters. The position peaked at $344K in Q4 2021. 870 funds tracked by Wall St. Rank hold WDAY as of Q1 2023.

  • Aspiriant LLC reported no remaining Workday position as of Q1 2023 after selling out during the quarter.
  • Aspiriant LLC sold 1,251 Workday shares in Q1 2023, an estimated $209K.
  • Aspiriant LLC first reported a position in Workday in Q2 2017 and held it in 16 quarters.
  • Aspiriant LLC's Workday position peaked at $344K in Q4 2021.
  • 870 funds tracked by Wall St. Rank held Workday as of Q1 2023.

Based on Aspiriant LLC's 13F filing for Q1 2023, filed 27 Apr 2023.